1
|
Frigori RB. Be positive: optimizing pramlintide from microcanonical analysis of amylin isoforms. Phys Chem Chem Phys 2018; 19:25617-25633. [PMID: 28905065 DOI: 10.1039/c7cp04074a] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Amylin, or human islet amyloid polypeptide (hIAPP), is a 37-residue hormone synergistic to insulin and co-secreted with it by β-cells in the pancreas. The deposition of its cytotoxic amyloid fibrils is strongly related to the progression of Type II diabetes (T2D) and islet graft failures. Notably, isoforms from some mammalian species, such as rats (rIAPP) and porcine (pIAPP), present a few key mutations preventing aggregation. This has lead to biotechnological development of drugs for adjunct therapies of T2D, such as pramlintide, a variant of hIAPP inspired by rIAPP whose proline substitutions have β-strand fibril-breaking properties. Ideally, such a drug should be formulated with insulin and co-administered, but this has been prevented by a poor solubility profile at the appropriate pH. Hopefully, this could be improved with appropriate point mutations, increasing the molecular net charge. Despite experimental progress, preliminary screening during rational drug design can greatly benefit from thermodynamic insight derived from molecular simulations. So we introduce microcanonical thermostatistics analysis of multicanonical (MUCA) simulations of wild-type amylin isoforms as a systematic assessment of protein thermostability. As a consequence of this comprehensive investigation, the most suitable single-point mutations able to optimize pramlintide are located among the wild-type amylin isoforms. In particular, we find that aggregation inhibition and increased solubility are inherited by pramlintide through further S20R substitution typical of pIAPP. Thus, we provide a consistent thermostatistical methodology to aid the design of improved adjunct therapies for T2D according to current clinical knowledge.
Collapse
Affiliation(s)
- Rafael B Frigori
- Universidade Tecnológica Federal do Paraná, Rua Cristo Rei 19, 85902-490, Toledo, PR, Brazil.
| |
Collapse
|
2
|
Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, Ragin A, Levine A, Miller E. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology 2015; 86:334-40. [PMID: 26718568 DOI: 10.1212/wnl.0000000000002277] [Citation(s) in RCA: 283] [Impact Index Per Article: 31.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2015] [Accepted: 08/17/2015] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To evaluate the frequency of HIV-associated neurocognitive disorder (HAND) in HIV+ individuals and determine whether the frequency of HAND changed over 4 years of follow-up. METHODS The Multicenter AIDS Cohort Study (MACS) is a prospective study of gay/bisexual men. Beginning in 2007, all MACS participants received a full neuropsychological test battery and functional assessments every 2 years to allow for HAND classification. RESULTS The frequency of HAND for the 364 HIV+ individuals seen in 2007-2008 was 33% and for the 197 HIV+ individuals seen at all time periods during the 2007-2008, 2009-2010, and 2011-2012 periods were 25%, 25%, and 31%, respectively. The overall frequency of HAND increased from 2009-2010 to 2011-2012 (p = 0.048). Over the 4-year study, 77% of the 197 HIV+ individuals remained at their same stage, with 13% showing deterioration and 10% showing improvement in HAND stage. Hypercholesterolemia was associated with HAND progression. A diagnosis of asymptomatic neurocognitive impairment was associated with a 2-fold increased risk of symptomatic HAND compared to a diagnosis of normal cognition. CONCLUSION HAND remains common in HIV+ individuals. However, for the majority of HIV+ individuals on combination antiretroviral therapy with systemic virologic suppression, the diagnosis of HAND is not a progressive condition over 4 years of follow-up. Future studies should evaluate longitudinal changes in HAND and specific neurocognitive domains over a longer time period.
Collapse
Affiliation(s)
- Ned Sacktor
- From the Department of Neurology, Johns Hopkins Bayview Medical Center (N.S.), and the Departments of Orthopaedic Surgery (R.L.S.) and Psychiatry (C.M.), Johns Hopkins University School of Medicine, Baltimore; the Department of Epidemiology (E.S.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Department of Psychiatry (J.T.B.), University of Pittsburgh, PA; the Department of Psychiatry (E.M.), Rush University School of Medicine, Chicago, IL; the Department of Radiology (A.R.), Northwestern University, Evanston, IL; and the Department of Neurology, David Geffen School of Medicine (A.L.), and the Department of Psychiatry (E.M.), University of California, Los Angeles.
| | - Richard L Skolasky
- From the Department of Neurology, Johns Hopkins Bayview Medical Center (N.S.), and the Departments of Orthopaedic Surgery (R.L.S.) and Psychiatry (C.M.), Johns Hopkins University School of Medicine, Baltimore; the Department of Epidemiology (E.S.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Department of Psychiatry (J.T.B.), University of Pittsburgh, PA; the Department of Psychiatry (E.M.), Rush University School of Medicine, Chicago, IL; the Department of Radiology (A.R.), Northwestern University, Evanston, IL; and the Department of Neurology, David Geffen School of Medicine (A.L.), and the Department of Psychiatry (E.M.), University of California, Los Angeles
| | - Eric Seaberg
- From the Department of Neurology, Johns Hopkins Bayview Medical Center (N.S.), and the Departments of Orthopaedic Surgery (R.L.S.) and Psychiatry (C.M.), Johns Hopkins University School of Medicine, Baltimore; the Department of Epidemiology (E.S.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Department of Psychiatry (J.T.B.), University of Pittsburgh, PA; the Department of Psychiatry (E.M.), Rush University School of Medicine, Chicago, IL; the Department of Radiology (A.R.), Northwestern University, Evanston, IL; and the Department of Neurology, David Geffen School of Medicine (A.L.), and the Department of Psychiatry (E.M.), University of California, Los Angeles
| | - Cynthia Munro
- From the Department of Neurology, Johns Hopkins Bayview Medical Center (N.S.), and the Departments of Orthopaedic Surgery (R.L.S.) and Psychiatry (C.M.), Johns Hopkins University School of Medicine, Baltimore; the Department of Epidemiology (E.S.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Department of Psychiatry (J.T.B.), University of Pittsburgh, PA; the Department of Psychiatry (E.M.), Rush University School of Medicine, Chicago, IL; the Department of Radiology (A.R.), Northwestern University, Evanston, IL; and the Department of Neurology, David Geffen School of Medicine (A.L.), and the Department of Psychiatry (E.M.), University of California, Los Angeles
| | - James T Becker
- From the Department of Neurology, Johns Hopkins Bayview Medical Center (N.S.), and the Departments of Orthopaedic Surgery (R.L.S.) and Psychiatry (C.M.), Johns Hopkins University School of Medicine, Baltimore; the Department of Epidemiology (E.S.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Department of Psychiatry (J.T.B.), University of Pittsburgh, PA; the Department of Psychiatry (E.M.), Rush University School of Medicine, Chicago, IL; the Department of Radiology (A.R.), Northwestern University, Evanston, IL; and the Department of Neurology, David Geffen School of Medicine (A.L.), and the Department of Psychiatry (E.M.), University of California, Los Angeles
| | - Eileen Martin
- From the Department of Neurology, Johns Hopkins Bayview Medical Center (N.S.), and the Departments of Orthopaedic Surgery (R.L.S.) and Psychiatry (C.M.), Johns Hopkins University School of Medicine, Baltimore; the Department of Epidemiology (E.S.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Department of Psychiatry (J.T.B.), University of Pittsburgh, PA; the Department of Psychiatry (E.M.), Rush University School of Medicine, Chicago, IL; the Department of Radiology (A.R.), Northwestern University, Evanston, IL; and the Department of Neurology, David Geffen School of Medicine (A.L.), and the Department of Psychiatry (E.M.), University of California, Los Angeles
| | - Ann Ragin
- From the Department of Neurology, Johns Hopkins Bayview Medical Center (N.S.), and the Departments of Orthopaedic Surgery (R.L.S.) and Psychiatry (C.M.), Johns Hopkins University School of Medicine, Baltimore; the Department of Epidemiology (E.S.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Department of Psychiatry (J.T.B.), University of Pittsburgh, PA; the Department of Psychiatry (E.M.), Rush University School of Medicine, Chicago, IL; the Department of Radiology (A.R.), Northwestern University, Evanston, IL; and the Department of Neurology, David Geffen School of Medicine (A.L.), and the Department of Psychiatry (E.M.), University of California, Los Angeles
| | - Andrew Levine
- From the Department of Neurology, Johns Hopkins Bayview Medical Center (N.S.), and the Departments of Orthopaedic Surgery (R.L.S.) and Psychiatry (C.M.), Johns Hopkins University School of Medicine, Baltimore; the Department of Epidemiology (E.S.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Department of Psychiatry (J.T.B.), University of Pittsburgh, PA; the Department of Psychiatry (E.M.), Rush University School of Medicine, Chicago, IL; the Department of Radiology (A.R.), Northwestern University, Evanston, IL; and the Department of Neurology, David Geffen School of Medicine (A.L.), and the Department of Psychiatry (E.M.), University of California, Los Angeles
| | - Eric Miller
- From the Department of Neurology, Johns Hopkins Bayview Medical Center (N.S.), and the Departments of Orthopaedic Surgery (R.L.S.) and Psychiatry (C.M.), Johns Hopkins University School of Medicine, Baltimore; the Department of Epidemiology (E.S.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; the Department of Psychiatry (J.T.B.), University of Pittsburgh, PA; the Department of Psychiatry (E.M.), Rush University School of Medicine, Chicago, IL; the Department of Radiology (A.R.), Northwestern University, Evanston, IL; and the Department of Neurology, David Geffen School of Medicine (A.L.), and the Department of Psychiatry (E.M.), University of California, Los Angeles
| |
Collapse
|
5
|
Hénin J, Fiorin G, Chipot C, Klein ML. Exploring Multidimensional Free Energy Landscapes Using Time-Dependent Biases on Collective Variables. J Chem Theory Comput 2009; 6:35-47. [PMID: 26614317 DOI: 10.1021/ct9004432] [Citation(s) in RCA: 302] [Impact Index Per Article: 20.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
A new implementation of the adaptive biasing force (ABF) method is described. This implementation supports a wide range of collective variables and can be applied to the computation of multidimensional energy profiles. It is provided to the community as part of a code that implements several analogous methods, including metadynamics. ABF and metadynamics have not previously been tested side by side on identical systems. Here, numerical tests are carried out on processes including conformational changes in model peptides and translocation of a halide ion across a lipid membrane through a peptide nanotube. On the basis of these examples, we discuss similarities and differences between the ABF and metadynamics schemes. Both approaches provide enhanced sampling and free energy profiles in quantitative agreement with each other in different applications. The method of choice depends on the dimension of the reaction coordinate space, the height of the barriers, and the relaxation times of degrees of freedom in the orthogonal space, which are not explicitly described by the chosen collective variables.
Collapse
Affiliation(s)
- Jérome Hénin
- Center for Molecular Modeling, Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, Institute for Computational Molecular Science and Department of Chemistry, Temple University, Philadelphia, Pennsylvania 19122, and Department of Physics and Beckman Institute for Advanced Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61820
| | - Giacomo Fiorin
- Center for Molecular Modeling, Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, Institute for Computational Molecular Science and Department of Chemistry, Temple University, Philadelphia, Pennsylvania 19122, and Department of Physics and Beckman Institute for Advanced Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61820
| | - Christophe Chipot
- Center for Molecular Modeling, Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, Institute for Computational Molecular Science and Department of Chemistry, Temple University, Philadelphia, Pennsylvania 19122, and Department of Physics and Beckman Institute for Advanced Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61820
| | - Michael L Klein
- Center for Molecular Modeling, Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, Institute for Computational Molecular Science and Department of Chemistry, Temple University, Philadelphia, Pennsylvania 19122, and Department of Physics and Beckman Institute for Advanced Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61820
| |
Collapse
|